Most people say they would prefer to die at home, but in reality most patients in the UK spend their final days in hospital ([WHO, 2004a](#bib19){ref-type="other"}). Over the last 30 years, hospices, palliative care teams and units have developed with the aim of improving care towards the end of life, and allowing people to die where they wish, if this is possible. Services have initially focused on patients with cancer, primarily because of the relative ease of predicting the course of this disease, and a national policy for supportive and palliative cancer care is now in place ([House of Commons Health Committee, 2004](#bib7){ref-type="other"}; [NICE, 2004a](#bib15){ref-type="other"}, [2004b](#bib16){ref-type="other"}). There is, therefore, increasing interest in Europe about whether data on place of death can be used as an interim measure of the success of services provided ([WHO, 2004a](#bib19){ref-type="other"}). Figures for England and Wales revealed a trend away from death in hospital or nursing homes to hospices between 1985 and 1994, but very little change in home deaths, which remained around 26%. However, this proportion varied between regions and was lowest in South East England across all age and cancer types ([Higginson *et al*, 1998](#bib4){ref-type="other"}). For common cancers, individual, disease-related and area of residence factors were consistently associated with, but not strongly predictive of place of death. Men, patients aged under 74 years, those with lung or colorectal cancer or living in more affluent areas were more likely to die at home than women, patients aged over 75 years, those with breast cancer or those living in less affluent areas ([Higginson *et al*, 1998](#bib4){ref-type="other"}, [1999](#bib5){ref-type="other"}).

The Thames Cancer Registry covers a population of 14 million people in South East England, an area with one of the highest concentrations of hospice and palliative care services in the UK ([Hospice Information, 2006](#bib6){ref-type="other"}). We used Registry data to describe trends in place of death for common cancers and compared these to the growth of palliative care services and nursing homes between 1985 and 2002. We then investigated the relationship between demographic, disease-related factors and individual place of death throughout the period, and the additional influence of area of residence between 1998 and 2002.

METHODS
=======

In the UK cancer registries record the occurrence of cancer in their residential populations as well as treatments given in the first 6 months after diagnosis. Information about death is provided by the National Health Service Central Register through the Office for National Statistics. Death certificates routinely record place of death and assign cancer as a main or contributing cause of death in part I of the certificate.

We extracted data on 216 404 residents in South East England who had been diagnosed with breast, lung, colorectal and prostate cancer between 1985 and 2002, and who died from their disease between 1985 and 2002. Cases where the only registration information was from the death certificate were not included. From death certificates, we classified death as occurring in NHS acute hospitals, hospices, long stay hospitals or nursing homes, private hospitals, at home or as unknown. We could identify nursing homes by their address, but death certificates do not distinguish deaths in hospital palliative care units from those in other wards.

We extracted data on hospice and palliative care services from Hospice Information directories for 1985--2002 ([Hospice Information, 2006](#bib6){ref-type="other"}) and calculated the number of hospice beds, home care teams, day care services, hospital palliative care or support teams and hospital support nurses in our area. We summed home care services regardless of their funding (independent, NHS and Macmillan Cancer Relief) or base (hospices, NHS hospital or community), although there was insufficient detail about Marie Curie home services to include these. We could not deduce team size or caseload. We also obtained aggregate data on numbers of beds in registered nursing homes from the Department of Health where this was available for 1991--2001. We first plotted the proportion of deaths occurring in each of home, hospital, hospice and nursing home against the growth of different services over time. Data on acute and general hospital beds in our area were available only between 1996 and 2002 and were not plotted.

We then took death in hospice, nursing home, NHS acute hospital and at home as our four dependent variables and fitted logistic regression models to identify individual demographic, disease-related and area of residence factors predicting in turn each of these outcomes versus the others. Our first analysis for the entire period 1985--2002 included sex, age at diagnosis, whether the diagnosis was based on clinical or microscopic evidence, primary site of cancer and treatment with surgery, radiotherapy, chemotherapy or hormone therapy. We also adjusted for year of death and years since diagnosis to examine trends over time. We grouped age into four bands: \<65 years, 65--74 years, 75--84 years and 85 years plus. Our second analysis explored the additional influence of area of residence for the years 1998--2002. For this, we assigned each individual to an electoral ward and a cancer network using their postcode of residence. We calculated the deprivation score for each ward using the income domain of the Indices of Multiple Deprivation (IMD) 2000 for England ([Department of Environment, 2000](#bib2){ref-type="other"}) and assigned individuals to a quintile of deprivation ranging from most (1) to least affluent (5) wards.

We present the results of logistic regression analyses as proportions of deaths occurring in each place for each factor. Proportions are easier to interpret than odds ratios, and were derived from a back calculation from the odds ratios obtained from the logistic regression analyses. We present unadjusted and adjusted proportions to show the effect of controlling for all other factors. Our large sample size means that many small differences reach statistical significance. We draw attention only to those factors producing at least five percentage points difference -- a difference which we believe a clinical service might be interested to explore further.

RESULTS
=======

The average age of death for patients in this cohort increased from 71.3 years in 1985 to 72.7 in 2002. The proportion dying at age of 85 years and over increased from 8 to 12% while the proportion dying between the age of 65 and 74 years dropped from 34 to 28%.

How has place of death changed?
-------------------------------

[Figure 1](#fig1){ref-type="fig"} suggests that the period 1985--2002 is best considered in two phases -- before and after 1994. In the first phase, hospital deaths declined from 67 to 44% -- a trend that appeared to be mirrored by a combined increase in home death from 17 to 30% and in hospice death from 8 to 20%. In the second phase, however, the movement away from hospital death appeared to partly reverse. Between 1995 and 2002 hospital death rose to 47%, nursing home death to 8%, hospice death remained stable and home deaths dropped to 23%. In 2002 -- the last year of the study -- home death and nursing home death home appear to have increased slightly and hospital death to have decreased. During 1992 and 1995 there were changes in processing and receipt of our registry data which may be responsible for the 'mirroring\' of trends in hospital and home deaths during this period. This artefact overlies but does not explain the reversal of overall trends which is also seen in national data for this period.

[Figure 2](#fig2){ref-type="fig"} shows that during the first phase, while home and hospice death increased, the provision of home care services and hospice beds also increased. From 1995 onwards while nursing home death and hospital death increased, nursing home beds and, to a lesser degree, the sum of hospital palliative care services (teams and nurses) also increased. For nursing home deaths, unlike hospice deaths, there is a lag of several years between the rise of available beds in these services and deaths within them. The decline in home death occurring after 1995 did not appear to follow a substantial drop in the provision of palliative home care or day care services, which both remained stable, although during this period the availability of nursing home beds was increasing.

Which individual and disease-related factors affect place of death?
-------------------------------------------------------------------

[Table 1](#tbl1){ref-type="table"} shows unadjusted and adjusted proportions of deaths in each place for individual demographic and disease-related factor over the entire study period. Hospital death was more likely for patients aged over 75, those with lung or breast cancer, a clinical rather than microscopic diagnosis, and those not receiving radiotherapy. Home death was more likely for those with colorectal cancer and those aged less than 75 years. Hospice death was also more likely for colorectal cancer and for those aged less than 75 years. Nursing home death increased with older age (4% for those aged 65--74 years and 12% of those aged over 85 years).

Did place of residence affect place of death between 1998 and 2002?
-------------------------------------------------------------------

Our analysis for the most recent years included area of residence as assessed by cancer network of residence and deprivation of ward of residence ([Table 2](#tbl2){ref-type="table"}). The results for demographic and disease-related factors were broadly similar to those in [Table 1](#tbl1){ref-type="table"}, although nursing home deaths become more likely for those with breast and prostate cancer. However, much more striking was the variation by area of residence. Concentrating on the nine of 13 cancer networks that we completely cover, the adjusted proportion of patients dying in hospital ranged from 39% in Sussex to 60% in West London. Home deaths ranged from 16% in Surrey, West Sussex and Hampshire to 27% in South Essex. Hospice death ranged from 10% in West London to 31% in Surrey, West Sussex and Hampshire. Nursing home deaths ranged from 4% in North London to 13% in Sussex. Of London networks, South East London had the lowest rate of hospital death (49%) and the highest rate of home death (23%). Patients from more deprived areas died more often in hospital and less often at home. There was no important deprivation gradient for nursing home or hospice death.

DISCUSSION
==========

Summary of main findings
------------------------

This study of 216 404 patients diagnosed and dying from four common cancers in South East England found an initial trend away from hospital death (67--44%) to home (17--30%) and hospice death (8--20%) between 1985 and 1994. After 1995 this trend partly reversed. By 2002, the proportion of hospital deaths rose to 47%, hospice deaths remained stable, home deaths dropped to 23% and nursing home deaths rose from 3 to 8%. The number and range of palliative care services increased but trends for hospice and nursing home death most clearly followed the numbers of beds available. Analysis of individual data showed that throughout the period disease-related factors had a modest influence on place of death. Patients with colorectal cancer were more likely to die at home and in hospices while patients with lung or breast cancer, no microscopic diagnosis and no radiotherapy were more likely to die in hospitals. However, between 1998 and 2002, age and place of residence were associated with most variation. Older patients were more likely to die in hospitals and nursing homes and less likely to die at home or in hospices. Patients from deprived areas were more likely to die in hospitals and less likely to die at home. There was significant variation in each place of death by cancer network of residence.

Limitations of this study
-------------------------

This population-based study used data collected from medical records and death certificates for routine cancer registration. Coding officers may have missed some deaths in new nursing homes and hospices when their addresses were unfamiliar in the early part of the study period. Lack of information on death certificate on deaths in hospital palliative care units and lack of data on hospital beds meant we could not explore these trends and it is possible that excluding patients for whom we had only death certificate data from the analysis introduced some bias. Important information on patient preference for place of death, functional status, presence of a carer at home, family support, and hospital and community services received in the weeks before death ([Grundy *et al*, 2004](#bib13){ref-type="other"}; [Gomes and Higginson, 2006](#bib12){ref-type="other"}) is not routinely collected and is therefore missing from the individual analyses.

Comparison to other findings
----------------------------

No other large UK studies have compared overall trends in place of death with the growth of services that might support patients to die in different places. However, one study of North West England between 1993 and 2000 found that proximity to a hospice or hospital increased the chances of dying there ([Gatrell *et al*, 2003](#bib10){ref-type="other"}). Studies in the US have also found that the availability of beds and physicians affects death in hospital ([Fisher *et al*, 2003a](#bib8){ref-type="other"}, [2003b](#bib9){ref-type="other"}). National bed data available for 1987 to 1994 when hospital deaths decreased showed a decline of 19% in the numbers of acute and general hospital beds ([Department of Health, 2006](#bib3){ref-type="other"}). It, therefore, seems likely that the initial trend for increasing home death was in part driven by the decreased availability of hospital beds and the growth of hospice and palliative home care services. However, it is more difficult to explain the reversal of the trend for home death after 1995 using the routine service data that is available. The number of home care teams did not decline, hospital palliative care services were only just beginning to increase and hospital beds did not increase nationally until 2001. We can speculate that the decline in home death was due to other changes in care at home including the ability of families to provide care, the prior move of some older adults into nursing homes and the move to GP cooperatives for out of hours care. These factors could all have led to increased hospital admission and fewer home deaths.

Turning to predictors of individual place of death, our finding that younger patients, patients with colorectal cancer and those living in more affluent areas died more often at home is consistent with ([Higginson *et al* 1998](#bib4){ref-type="other"}, [1999](#bib5){ref-type="other"}) analyses of a partial national registration dataset up until 1994 . However, we found that patients with breast and lung cancer were more likely to die in hospital and we were further able to show that hospital death was associated with lack of microscopic diagnosis, and no radiotherapy treatment. This suggests the late admission of patients with advanced stage of disease. Conversely our finding that a microscopically confirmed diagnosis and radiotherapy treatment were associated with home and hospice death suggests that some time within 'the system\' may allow for referral to supportive services ([Burge *et al*, 2003](#bib1){ref-type="other"}). A recent systematic review of factors predicting home death by [Gomes and Higginson (2006)](#bib12){ref-type="other"} found that the six strongest predictors were patients\' low functional status, their preferences, home care and its intensity, living with relatives and extended family support. Our new finding that cancer network is an important cause of variation in home death is consistent with this, and probably represents a combination of difference by area in access to home care services, and the nearness of relatives and extended family. It is very unlikely to represent underlying variation in patients\' preference for place of death or functional status. Finally our finding that patients from more deprived areas were equally likely to die in hospices and nursing homes as those from affluent areas, contradicts the view that the latter may access these services more often. Inequalities in hospital and home death do, however, persist.

Implications for practice and policy
------------------------------------

Our findings reveal that despite increased investment in and provision of palliative care services, cancer patients in South East England remain twice as likely to die in hospital (47%) than at home (23%). The proportion dying at home is now lower than a decade ago, lower than elsewhere in the UK, and far lower than most patients would prefer. Recent national policy has set out the evidence that coordinated palliative care services can allow more people to die at home if they wish ([NICE, 2004a](#bib15){ref-type="other"}, [2004b](#bib16){ref-type="other"}) and advocated equity of choice in final place of care. This study covers a period before most recent initiatives ([Gold Standards Framework, 2006](#bib11){ref-type="other"}; [Marie Curie, 2006](#bib14){ref-type="other"}) but the variation it finds underlines the need for much more active local surveillance to drive these policies. It also suggests that opportunities exist to learn from differing strategies, organisation and practice within cancer networks. For example, London networks might ask what it is about service provision in South East London that produces rates of home death similar to those outside London. Networks outside London might ask why hospice deaths are sometimes so high and whether nursing homes are preventing hospital admission and providing better symptom control. Our data also suggest that a good place for clinicians in primary care and acute trusts to start identifying patients in the palliative stage of disease and determining their preference for avoiding or planning admission would be the clinical diagnosis of lung or breast cancer in patients living in deprived areas for whom radiotherapy treatment is not planned. The effect of any change in practice across a network can be monitored easily by the routine work of cancer registries.

Further research
----------------

We do not yet fully understand why place of death varies across the UK, how the nexus of factors around the patient operate together to influence this ([Gomes and Higginson, 2006](#bib12){ref-type="other"}) and why home deaths have declined and remain so low in South East England. The imaginative use of available routine data as part of the development of cancer intelligence could help us see more clearly what is happening. For example, trends within individual cancer networks could reveal the influence of different historical patterns of service provision. Ecological studies could show us what happens when a new service such as a hospice opens locally. Mapping rates geographically by primary care trust could show the influence of services (beds and teams) and workforce (district nurses ([Shipman *et al*, 2005](#bib17){ref-type="other"}), Marie Curie nurses and out of hours care by general practitioners). Studies of how patients move between different services and the interdependence between services are also required. Linking hospital episode statistics data with cancer registration data will, for example, allow us to explore where patients with different cancers are admitted to hospital from, how long they stay and where they are discharged to in the last months of life. The influence that admission has on rate of death in different trusts or primary care trusts explored in a similar way to US studies have done ([Wennberg *et al*, 2004](#bib18){ref-type="other"}). Qualitative case studies of selected areas could then focus on explaining how different patterns of care are perpetuated, or how change has occurred. Finally in the context of an ageing population, changes in migration and kinship patterns we need to determine older people\'s preference for death in institutions, ensure that the information we have on what currently occurs is available and public so that where possible people may make their own choices in planning care towards the end of life ([WHO, 2004b](#bib20){ref-type="other"}).

We thank Hospice Information for providing us with Hospice Directories, the Department of Health for confirming the nursing home data and colleagues for helpful comments on an earlier draft of this paper.

![Trends for place of death for patients with breast, colorectal, lung and prostate cancer in South East England 1985--2002. *Note*: Figure excludes the proportion dying in private hospitals and patients where place of death was not known.](95-6603305f1){#fig1}

![Trends in place of death for patients with breast, lung, colorectal and prostate cancer and the growth of services for care towards the end of life in South East England 1985--2002. *Note*: Department of Health Data is only available for 1991--2001 and Hospice Information Directories are not available for 1986 and 1989.](95-6603305f2){#fig2}

###### 

Associations of individual demographic and disease-related factors with place of death for cancer patients who died 1985--2002 in South East England

                                    **Acute hospital**   **Home**   **Hospice**   **Nursing home**                                                                               
  -------------------------------- -------------------- ---------- ------------- ------------------ ---------- --------- -------- --------- --------- ------ --------- --------- ---------
  *Age group*                                                                                                                                                                         
   \<65                                   28 818            47          47             17 332           28        28      12 032     20        20      956       2         2      61 670
   65-74                                  34 777            49          47             18 104           26        26      13 045     18        20      2467      3         4      70 665
   75-84                                  33 811            52          48             13 960           22        23      10 566     16        18      4721      7         8      64 921
   85+                                    10 512            55          50              3717            19        22       2046      11        12      2375     12        12      19 148
                                                                                                                                                                                      
   Test for                           *χ*^2^ (1 df)       574.1        51.1                          1036\. 6    410.7              753.7     271.2           4322.2    3206.3        
   Trend                                   *P*           \<0.001      \<0.001                        \<0.001    \<0.001            \<0.001   \<0.001          \<0.001   \<0.001       
                                                                                                                                                                                      
  *Sex*                                                                                                                                                                          
   Male                                   60 626            51          51             29 552           25        25      19 793     17        17      5005      4         4      118 630
   Female                                 47 292            48          49             23 561           24        23      17 896     18        19      5514      6         6      97 774
                                                                                                                                                                                      
   Test for                           *χ*^2^ (1 df)       160.5        46.7                            19.2      42.8               97.6      92.0             232.3     139.3        
   Heterogeneity                           *P*           \<0.001      \<0.001                        \<0.001    \<0.001            \<0.001   \<0.001          \<0.001   \<0.001       
                                                                                                                                                                                      
  *Basis of diagnosis*                                                                                                                                                           
   Clinical                               29 382            57          57             10 763           21        21       6697      13        13      3283      6         6      51 936
   Microscopic                            78 536            48          52             42 350           26        23      30 992     19        16      7236      4         5      164 468
                                                                                                                                                                                      
   Test for                           *χ*^2^ (1 df)       1222.9       219.3                          536.2      128.9              959.3     212.1            311.8     55.1         
   Heterogeneity                           *P*           \<0.001      \<0.001                        \<0.001    \<0.001            \<0.001   \<0.001          \<0.001   \<0.001       
                                                                                                                                                                                      
  *Site*                                                                                                                                                                              
   Colorectal                             23 203            46          46             13 381           26        26       9873      19        19      2705      5         5      50 937
   Lung                                   54 794            54          54             24 738           24        23      16 166     16        16      3575      4         4      102 071
   Breast                                 17 375            47          56              9140            24        21       6904      18        14      2304      6         5      37 340
   Prostate                               12 546            48          52              5854            22        21       4746      18        18      1935      7         6      26 056
                                                                                                                                                                                      
   Test for                           *χ*^2^ (3 df)       1168.1       837.7                          147.8      320.6              354.4     294.2            910.8     115.9        
   Heterogeneity                           *P*           \<0.001      \<0.001                        \<0.001    \<0.001            \<0.001   \<0.001          \<0.001   \<0.001       
                                                                                                                                                                                      
  *Had noninvestigative surgery*                                                                                                                                                 
   No                                     78 702            51          51             36 944           24        24      25 189     16        16      7527      5         5      153 570
   Yes                                    29 216            46          54             16 169           26        22      12 500     20        17      2992      5         5      62 834
                                                                                                                                                                                      
   Test for                           *χ*^2^ (1 df)       402.2        109.0                           67.6      61.6               376.8      0.3              1.9       1.1         
   Heterogeneity                           *P*           \<0.001      \<0.001                        \<0.001    \<0.001            \<0.001    0.618            0.171     0.298        
                                                                                                                                                                                      
  *Had radiotherapy*                                                                                                                                                             
   No                                     79 090            52          52             34 962           23        23      24 472     16        16      8182      5         5      151 223
   Yes                                    28 828            44          43             18 151           28        27      13 217     20        20      2337      4         5      65 181
                                                                                                                                                                                      
   Test for                           *χ*^2^ (1 df)       1183.5      1240.9                          548.2      329.8              528.9     425.9            323.6      2.5         
   Heterogeneity                           *P*           \<0.001      \<0.001                        \<0.001    \<0.001            \<0.001   \<0.001          \<0.001    0.117        
                                                                                                                                                                                      
  *Had chemotherapy*                                                                                                                                                             
   No                                     94 814            50          50             45 221           24        24      31 764     17        17      9976      5         5      187 856
   Yes                                    13 104            46          49              7892            28        25      5 925      21        18      543       2         3      28 548
                                                                                                                                                                                      
   Test for                           *χ*^2^ (1 df)       206.7        12.7                           170.4      20.9               253.8     10.6             568.8     125.6        
   Heterogeneity                           *P*           \<0.001      \<0.001                        \<0.001    \<0.001            \<0.001    0.001           \<0.001   \<0.001       
                                                                                                                                                                                      
  *Had hormone therapy*                                                                                                                                                          
   No                                     85 818            50          50             41 640           24        24      29 243     17        17      7631      4         4      170 033
   Yes                                    22 100            48          49             11 473           25        25       8446      18        18      2888      6         5      46 371
                                                                                                                                                                                      
   Test for                           *χ*^2^ (1 df)       115.2        23.8                            1.3        8.8               26.1       9.1             236.5     46.6         
   Heterogeneity                           *P*           \<0.001      \<0.001                         0.263      0.003             \<0.001    0.003           \<0.001   \<0.001       
                                                                                                                                                                                      
  *Year of death*                                                                                                                                                                
   1985                                    3278             67          67              847             17        17       388        8         8      191       4         4       4866
   1986                                    5473             62          64              1792            20        19       996       11        10      328       4         4       8833
   1987                                    5487             57          61              2294            24        22       1183      12        11      330       3         3       9644
   1988                                    5976             54          59              2660            24        22       1592      14        12      396       4         3      10 989
   1989                                    6485             53          58              3212            26        24       1718      14        12      425       3         3      12 215
   1990                                    6558             52          57              3415            27        25       1926      15        13      420       3         3      12 659
   1991                                    6392             50          56              3506            28        26       2074      16        14      453       4         3      12 738
   1992                                    6274             50          55              3318            26        24       2296      18        16      440       3         3      12 660
   1993                                    6536             45          50              4345            30        28       2834      19        17      507       3         3      14 681
   1994                                    5342             44          50              3730            30        28       2505      20        17      339       3         2      12 279
   1995                                    6055             47          54              3170            25        22       2242      17        15      398       3         2      12 827
   1996                                    4917             46          53              2625            25        22       2135      20        17      583       5         5      10 704
   1997                                    5606             47          54              2765            23        21       2188      18        15      631       5         4      11 930
   1998                                    6463             48          55              3062            23        20       2709      20        17      927       7         6      13 501
   1999                                    6653             48          55              3247            24        21       2675      19        17      920       7         5      13 798
   2000                                    6849             49          56              3008            22        20       2685      19        17      1019      7         6      13 893
   2001                                    6812             49          55              2892            21        19       2737      20        17      1019      7         6      13 919
   2002                                    6762             47          54              3225            23        21       2806      20        17      1193      8         7      14 268
                                                                                                                                                                                      
   Test for                           *χ*^2^ (1 df)       906.0        353.0                           68.3      119.2              949.9     672.1           1087.3     648.8        
   Trend                                   *P*           \<0.001      \<0.001                        \<0.001    \<0.001            \<0.001   \<0.001          \<0.001   \<0.001       

Adjusted model includes: age, sex, basis of diagnosis, site, treatment (surgery, radiotherapy, chemotherapy or hormone therapy), year of death and years since diagnosis.

###### 

Associations of individual demographic, disease-related and area of residence with place of death for patients who died from Breast, lung, colorectal or prostate cancer between 1998 and 2002 in South East England

                                       **Acute hospital**   **Home**   **Hospice**   **Nursing home**                                                                                
  ------------------------------------ -------------------- ---------- ------------- ------------------ --------- ---------- -------- --------- --------- ------ --------- --------- --------
  *Age group*                                                                                                                                                                        
   \<65                                8756                 45         45            5085               26        26         4578     23        23        411    2         2         19 521
   65-74                               10 018               48         46            4963               24        24         4454     21        22        1146   5         5         21 058
   75-84                               10 790               50         48            4180               20        21         3727     17        19        2263   11        10        21 377
   85+                                 3975                 54         50            1206               16        18         853      11        13        1258   17        14        7423
                                                                                                                                                                                      
   Test for                            *χ*^2^ (1 df)        219.0      55.6                             421.17    213.1               553.8     268.8            2016.8    1293.1     
   Trend                               *P*                  \<0.001    \<0.001                          \<0.001   \<0.001             \<0.001   \<0.001          \<0.001   \<0.001    
                                                                                                                                                                                      
  *Sex*                                                                                                                                                                              
   Male                                18 074               49         49            8369               23        23         7068     19        19        2305   6         6         36 629
   Female                              15 465               47         47            7065               22        22         6544     20        20        2773   8         10        32 750
                                                                                                                                                                                      
   Test for                            *χ*^2^ (1 df)        31.2       24.0                             16.3      10.0                5.2       5.7              119.7     122.8      
   Heterogeneity                       *P*                  \<0.001    \<0.001                          \<0.001   0.002               0.023     0.017            \<0.001   \<0.001    
                                                                                                                                                                                      
  *Basis of diagnosis*                                                                                                                                                               
   Clinical                            8462                 56         56            2755               18        18         1977     13        13        1472   10        10        15 002
   Microscopic                         25 077               46         49            12 679             23        21         11 635   21        18        3606   7         9         54 377
                                                                                                                                                                                      
   Test for                            *χ*^2^ (1 df)        495.0      192.4                            165.9     56.3                493.1     159.9            173.2     6.5        
   Heterogeneity                       *P*                  \<0.001    \<0.001                          \<0.001   \<0.001             \<0.001   \<0.001          \<0.001   0.011      
                                                                                                                                                                                      
  *Site*                                                                                                                                                                             
   Colorectal                          7528                 45         45            3799               23        23         3564     21        21        1370   8         8         16 714
   Lung                                15 992               53         54            6833               23        22         5429     18        18        1460   5         5         30 306
   Breast                              5853                 45         51            2821               22        19         2722     21        18        1184   9         10        13 026
   Prostate                            4166                 45         44            1981               21        20         1897     20        22        1064   11        12        9333
                                                                                                                                                                                      
   Test for                            *χ*^2^ (3 df)        421.7      326.2                            12.1      50.3                102.9     106.7            565.1     315.6      
   Heterogeneity                       *P*                  \<0.001    \<0.001                          0.007     \<0.001             \<0.001   \<0.001          \<0.001   \<0.001    
                                                                                                                                                                                      
  *Had noninvestigative surgery*                                                                                                                                                     
   No                                  24 850               50         50            10 836             22        22         9110     18        18        3646   7         7         49 630
   Yes                                 8689                 44         50            4598               23        22         4502     23        20        1432   7         7         19 749
                                                                                                                                                                                      
   Test for                            *χ*^2^ (1 df)        208.3      1.1                              17.1      0.1                 176.0     12.1             0.2       0.9        
   Heterogeneity                       *P*                  \<0.001    0.300                            \<0.001   0.792               \<0.001   0.001            0.663     0.341      
                                                                                                                                                                                      
  *Had radiotherapy*                                                                                                                                                                 
   No                                  25 031               51         51            10 122             21        21         8981     18        18        3937   8         8         49 142
   Yes                                 8508                 42         41            5312               26        25         4631     23        23        1141   6         8         20 237
                                                                                                                                                                                      
   Test for                            *χ*^2^ (1 df)        452.2      525.8                            263.5     143.1               192.3     162.9            117.8     2.4        
   Heterogeneity                       *P*                  \<0.001    \<0.001                          \<0.001   \<0. 001            \<0.001   \<0.001          \<0.001   0.122      
                                                                                                                                                                                      
  *Had chemotherapy*                                                                                                                                                                 
   No                                  27 748               49         49            11 977             21        21         10 409   19        19        4764   8         8         56 216
   Yes                                 5791                 44         47            3457               26        23         3203     24        20        314    2         5         13 163
                                                                                                                                                                                      
   Test for                            *χ*^2^ (1 df)        122.7      25.4                             150.9     25.9                227.3     24.1             508.2     97.0       
   Heterogeneity                       *P*                  \<0.001    \<0.001                          \<0.001   \<0.001             \<0.001   \<0.001          \<0.001   \<0.001    
                                                                                                                                                                                      
  *Had hormone therapy*                                                                                                                                                              
   No                                  27 739               50         50            12 320             22        22         10 839   19        19        3655   7         7         55 958
   Yes                                 5800                 43         46            3114               23        25         2773     21        20        1423   11        7         13 421
                                                                                                                                                                                      
   Test for                            *χ*^2^ (1 df)        174.6      28.8                             8.8       21.9                11.5      2.3              259.4     8.9        
   Heterogeneity                       *P*                  \<0.001    \<0.001                          0.003     \<0.001             0.001     0.130            \<0.001   0.003      
                                                                                                                                                                                      
  *Network of residence*                                                                                                                                                             
   North East London                   3946                 56         56            1353               19        19         1346     19        19        347    5         5         7080
   North London                        3314                 54         55            1224               20        19         1173     19        20        261    4         4         6128
   South East London                   3533                 49         49            1697               24        23         1549     22        22        328    5         5         7204
   South West London                   2899                 49         51            1111               19        17         1472     25        27        313    5         5         5886
   West London                         3988                 58         60            1391               20        19         693      10        10        417    6         6         6829
   TCR part of Mount Vernon            2459                 50         53            1415               29        26         488      10        11        458    9         9         4924
   South Essex                         2121                 52         54            1165               29        27         415      10        11        338    8         8         4067
   Kent & Medway                       3663                 42         42            2139               24        23         2186     25        26        688    8         7         8793
   Surrey, West Sussex and Hampshire   2688                 43         48            1232               20        16         1771     28        31        349    6         5         6262
   Sussex                              2642                 38         39            1515               22        20         1625     23        25        1046   15        13        7001
   TCR part of Central South Coast     327                  25         25            249                19        18         367      28        32        150    12        10        1301
   TCR part of Mid Anglia              1734                 52         53            791                24        22         473      14        15        328    10        9         3360
   TCR part of West Anglia             201                  41         45            140                28        24         48       10        11        48     10        9         492
   Other/NK                            24                   46         55            12                 23        21         6        12        6         7      13        12        52
                                                                                                                                                                                      
   Test for                            *χ*^2^ (12 df)       1361.2     1219.7                           399.9     401.8               1613.5    1687.6           943.1     690.8      
   Heterogeneity                       *P*                  \<0.001    \<0.001                          \<0.001   \<0.001             \<0.001   \<0.001          \<0.001   \<0.001    
                                                                                                                                                                                      
  *IMD*                                                                                                                                                                              
   Most affluent 1                     5020                 42         42            2926               25        25         2458     21        21        896    8         8         11 850
   2                                   5965                 46         45            3106               24        23         2449     19        21        1125   9         8         13 071
   3                                   6754                 48         47            3177               23        22         2620     19        22        1099   8         7         13 936
   4                                   7692                 51         48            3235               21        20         2891     19        24        1123   7         7         15 181
   Least affluent 5                    8105                 53         49            2988               19        18         3190     21        25        834    5         7         15 330
   NK                                  3                    27         23            2                  18        17         4        36        72        1      9         5         11
                                                                                                                                                                                      
   Test for                            *χ*^2^ (1 df)        362.7      92.2                             132.4     152.0               0.8       58.9             67.5      4.5        
   Trend                               *P*                  \<0.001    \<0.001                          \<0.001   \<0.001             0.387     \<0.001          \<0.001   0.035      

Adjusted model includes: age, sex, basis of diagnosis, site, treatment (surgery, radiotherapy, chemotherapy or hormone therapy), cancer network of residence and deprivation.
